scholarly journals Smart drugs et nootropiques

2021 ◽  
pp. 97-110
Author(s):  
Félix Denis
Keyword(s):  
2021 ◽  
Vol 15 (11) ◽  
pp. 2956-2957
Author(s):  
Gul Afshan ◽  
Ponum Mirani ◽  
Imtiaz Aslam ◽  
Sobia Ibrahim

Aim: Effects of available weight reducing drugs on the weights of a normal albino mice. Methodology: In this study, total 39 adult albino mice were used and were divided in three groups containing 13 animals in each. Group I served as control and was given 1 ml of distilled water once a day for 8 weeks. Group II and Group III served as experimental group and mice in these groups were given 0.5 mg of Slim Smart and Ultra Slim Plus drugs dissolved in 1 ml of distilled water respectively once a day for 8 weeks. To support these results weights of kidneys were also measured and relative tissue width index was calculated and compared with control group. Results: The weight of the animals increased in the experimental groups as compared to the control group. The overall difference for final weight among three groups was highly significant with p-value <0.01. When final weight compared group wise, the experimental groups had significantly higher weight as compared to control with p-values <0.01and 0.028 Conclusion: Both Ultra Slim Plus and Slim Smart drugs cause weight to increase in the individuals who are not obese and have BMI in normal range Keywords: Weight loss, Garcinia Cambodia, kidney, Albino mice


2019 ◽  
Vol 55 (4) ◽  
pp. 613-621
Author(s):  
Bianca de Oliveira Cata Preta ◽  
Vanessa Iribarrem Avena Miranda ◽  
Andréa Dâmaso Bertoldi
Keyword(s):  

2019 ◽  
Vol 14 ◽  
pp. 33-39 ◽  
Author(s):  
Jacqueline Champagne ◽  
Benjamin Gardner ◽  
Eleanor J Dommett
Keyword(s):  

2005 ◽  
Vol 6 (6) ◽  
pp. 362
Author(s):  
Pat McCaffrey
Keyword(s):  

The Lancet ◽  
2008 ◽  
Vol 372 (9634) ◽  
pp. 198-199 ◽  
Author(s):  
Steven Rose
Keyword(s):  

2017 ◽  
Vol 67 (656) ◽  
pp. 100-101 ◽  
Author(s):  
Paul J Nicholson ◽  
Nigel Wilson
Keyword(s):  

2014 ◽  
Vol 10 (5) ◽  
pp. 301 ◽  
Author(s):  
Maurizio Coppola, MD ◽  
Raffaella Mondola, MD

Epidemiological data confirm that the use of new psychoactive substances is on the rise around the world.1 Numerous reports have described medical emergencies associated with the consumption of unconventional drugs of misuse bought in “head” or “smart” shops or online.1 New psychoactive substances, also referred as “legal highs,” “smart drugs,” or “research chemicals,” are a large group of both plant derivatives and synthetic compounds, also in combination, purposefully designed as legal alternatives to illicit substances of abuse. The most popular and widely-spread new psychoactive substances are synthetic cannabinoids and synthetic cathinones, however, various different compounds such as amphetamine-like molecules, arylcyclohexylamines, synthetic hallucinogens, prescription drugs and hormones have been found in recreational products marketed as legal highs.1


Sign in / Sign up

Export Citation Format

Share Document